A popular diabetes drug just got a major new approval—and it could be a game-changer for millions of Americans at risk for ...

We recently compiled a list of the 12 Best Blue Chip Stocks to Buy Under $100. In this article, we are going to take a look ...

Amycretin, a novel once-weekly subcutaneous GLP-1 and amylin receptor agonist, was safe compared with other incretin-based ...

Healthcare stocks have been under the weather for the past few years, underperforming the broader market’s rally despite ...